Survivin-targeted nanoparticles for pancreatic tumor imaging in mouse model
Authors:
- 1 August 2016
- journal article
- Published by Elsevier in Nanomedicine: Nanotechnology, Biology and Medicine
- Vol. 12 (6) , 1651-1661
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Pancreatic AdenocarcinomaNew England Journal of Medicine, 2014
- Anti-CXCR4 monoclonal antibody conjugated to ultrasmall superparamagnetic iron oxide nanoparticles in an application of MR molecular imaging of pancreatic cancer cell linesActa Radiologica, 2012
- Paramagnetic nanoparticles as potential MRI contrast agents: characterization, NMR relaxation, simulations and theoryMagnetic Resonance Materials in Physics, Biology and Medicine, 2012
- New biomarkers and targets in pancreatic cancer and their application to treatmentNature Reviews Gastroenterology & Hepatology, 2012
- Cancer Targeted Metallic Nanoparticle: Targeting Overview, Recent Advancement and Toxicity ConcernCurrent Pharmaceutical Design, 2011
- In vivo diagnosis of murine pancreatic intraepithelial neoplasia and early-stage pancreatic cancer by molecular imagingProceedings of the National Academy of Sciences, 2011
- Markers of Pancreatic Cancer: Working Toward Early DetectionClinical Cancer Research, 2011
- Molecular Magnetic Resonance Contrast Agents for the Detection of Cancer: Past and PresentSeminars in Oncology, 2011
- Molecular Imaging of Pancreatic Cancer in an Animal Model Using Targeted Multifunctional NanoparticlesGastroenterology, 2009
- Targeted Nanoparticles for Imaging Incipient Pancreatic Ductal AdenocarcinomaPLOS Medicine, 2008